Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.
Mechanically ventilated patients’ respiratory function can be improved with pulmonary rehabilitation, especially IMT and NMES.
Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.
Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.